ArticleJCI insight2021

Targeting CDK4 overcomes EMT-mediated tumor heterogeneity and therapeutic resistance in KRAS-mutant lung cancer.

Aparna Padhye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.